BackAmarantus BioScience Holdings Overview

Amarantus BioScience Holdings Total Liabilities

Latest total liabilities for AMBS: $35M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$34.92M
↑ 0.48% YoYΔ $168477.00 vs prior year quarter

Peer trimmed avg / median

Loading

Amarantus BioScience Holdings Total Liabilities History

Loading

Amarantus BioScience Holdings vs. peers: Total Liabilities Comparison

Loading

Amarantus BioScience Holdings Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Amarantus BioScience Holdings (AMBS) FAQ

As of the most recent data (March 2023), AMBS shows a total liabilities of $35M. That compares with $35M in the prior-year period — up 0.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AMBS's total liabilities is now $35M (was $35M) — a 0.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Amarantus BioScience Holdings is outperforming or lagging.

Tracking AMBS's total liabilities over time shows whether Amarantus BioScience Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $35M That compares with $35M in the prior-year period — up 0.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Amarantus BioScience Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $35M) with ownership activity and broader fundamentals.

Amarantus BioScience Holdings's total liabilities is $35M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.

Questions & Answers